Market Tracker

12/19 6:05pm ET

Vanguard Health Care Index Fund ETF Shares (VHT)

129.15
Data as of Dec 19
 +0.72 / +0.56%
Today’s Change
99.45
Today|||52-Week Range
131.10
+27.74%
Year-to-Date
VHT Regular Dividend: VHT began trading ex-dividend on 12/18/14. A $1.285 dividend will be paid to shareholders of record as of 12/22/14.

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). It attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

Performance

1 month+4.21% 3 years+31.58%
3 months+9.55% 5 years+20.89%
1 year+31.28% Since inception+10.49%
Data through 12/20/2014

Quote Details

Previous close$128.43
Open day’s range128.15 – 129.71
Net asset value (NAV)129.05 (12/19/2014)
Daily volume398,360
Average volume (3 months)372,751
Data as of 3:59pm ET, 12/19/2014

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+20.89%+21.83%
Expense Gross exp ratio0.14%0.44%
Risk 5 year sharpe ratio1.671.50
Net assets$4.6B$1.6B
Average market cap$48.2B$34.2B
Average P/E25.725.9
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
IXJ iShares Global Healthcare ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.60%
PFE Pfizer Inc6.21%
MRK Merck & Co Inc5.48%
GILD Gilead Sciences Inc4.77%
AMGN Amgen Inc3.95%
ABBV AbbVie Inc3.47%
BMY Bristol-Myers Squibb Company3.08%
UNH UnitedHealth Group Inc3.01%
CELG Celgene Corp2.86%
BIIB Biogen Idec Inc2.29%